RSS-Feed abonnieren
DOI: 10.1055/s-0031-1298785
Hyaluronic Acid Fillers: History and Overview
Publikationsverlauf
Publikationsdatum:
28. Dezember 2011 (online)

ABSTRACT
Hyaluronic acid (HA) fillers have many favorable characteristics that make it a popular injectable filler device. Its minimal immunogenicity and relative ease of use has helped HA become the most commonly used injectable filler today. A brief history of injectable fillers, the various injection techniques, and legal ramifications are discussed. A review of the most recent literature compares the efficacy and safety of HA to other injectable filler substances.
KEYWORDS
Hyaluronic acid - fillers - Restylane - Perlane - Juvederm
REFERENCES
- 1
Neuber F.
Fat grafting.
Chir Kongr Verhandl Dtsch Ges Chir.
1893;
22
66
MissingFormLabel
- 2
Gersuny R.
Ueber eine subcutyane Prosthese.
Z Heilk.
1900;
30
1-5
MissingFormLabel
- 3 U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Sulfanilamide
Disaster. Available at: http://www.fda.gov/AboutFDA/WhatWeDo/History/ProductRegulation/SulfanilamideDisaster/default.htm Last accessed, December 15, 2011
MissingFormLabel
- 4
Matton G, Anseeuw A, De Keyser F.
The history of injectable biomaterials and the biology of collagen.
Aesthetic Plast Surg.
1985;
9
133-140
MissingFormLabel
- 5
Paraffingranulome S.
Munch Med Wochenschr.
1922;
69
215-220
MissingFormLabel
- 6 Orentreich D S, Orentreich N. Injectable fluid silicone. In: Roenigk R K, Roenigk Jr H H, eds. Dermatologic Surgery: Principles and Practice. New York: Marcel Dekker; 1989: 1349-1395
MissingFormLabel
- 7
Webster R C, Fuleihan N S, Gaunt J M et al..
Injectable silicone for small augmentations: twenty-year experience in humans.
Am J Cosm Surg.
1984;
1
1-7
MissingFormLabel
- 8
Landman M D, Strahan R W, Ward P H.
Chin augmentation with polytef paste injection.
Arch Otolaryngol.
1972;
95
72-75
MissingFormLabel
- 9
Ashinoff R.
Overview: soft tissue augmentation.
Clin Plast Surg.
2000;
27
479-487
MissingFormLabel
- 10 U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Approved
wrinkle fillers. Available at: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/CosmeticDevices/WrinkleFillers/ucm227749.htm Last accessed, December 15, 2011
MissingFormLabel
- 11
Krauss M C.
Recent advances in soft tissue augmentation.
Semin Cutan Med Surg.
1999;
18
119-128
MissingFormLabel
- 12
Duranti F, Salti G, Bovani B, Calandra M, Rosati M L.
Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological
study.
Dermatol Surg.
1998;
24
1317-1325
MissingFormLabel
- 13
Lowe N J, Maxwell C A, Lowe P, Duick M G, Shah K.
Hyaluronic acid skin fillers: adverse reactions and skin testing.
J Am Acad Dermatol.
2001;
45
930-933
MissingFormLabel
- 14
Maas C S.
Characteristics of implant materials.
Arch Facial Plast Surg.
2000;
2
67
MissingFormLabel
- 15
Micheels P.
Human anti-hyaluronic acid antibodies: is it possible?.
Dermatol Surg.
2001;
27
185-191
MissingFormLabel
- 16
Fernández-Aceñero M J, Zamora E, Borbujo J.
Granulomatous foreign body reaction against hyaluronic acid: report of a case after
lip augmentation.
Dermatol Surg.
2003;
29
1225-1226
MissingFormLabel
- 17
Vartanian A J, Frankel A S, Rubin M G.
Injected hyaluronidase reduces restylane-mediated cutaneous augmentation.
Arch Facial Plast Surg.
2005;
7
231-237
MissingFormLabel
- 18
Rohrich R J, Nguyen A T, Kenkel J M.
Lexicon for soft tissue implants.
Dermatol Surg.
2009;
35
(Suppl 2)
1605-1611
MissingFormLabel
- 19 U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Restylane™
injectable gel - P020023. Available at: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm082242.htm Last accessed, December 15, 2011
MissingFormLabel
- 20
ASPS & ASAPS Advisory .
Plast Reconstr Surg.
2006;
118
(Suppl 3)
129-132S
MissingFormLabel
- 21
Baumann L S, Shamban A T, Lupo M P JUVEDERM vs. ZYPLAST Nasolabial Fold Study Group et al.
Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen:
a multicenter, double-masked, randomized, within-subject study.
Dermatol Surg.
2007;
33
(Suppl 2)
S128-S135
MissingFormLabel
- 22
Lupo M P, Smith S R, Thomas J A, Murphy D K, Beddingfield III F C.
Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial
folds.
Plast Reconstr Surg.
2008;
121
289-297
MissingFormLabel
- 23
Narins R S, Brandt F, Leyden J, Lorenc Z P, Rubin M, Smith S.
A randomized, double-blind, multicenter comparison of the efficacy and tolerability
of Restylane versus Zyplast for the correction of nasolabial folds.
Dermatol Surg.
2003;
29
588-595
MissingFormLabel
- 24
Moers-Carpi M M, Vogt S, Santos B M, Planas J, Vallve S R, Howell D J.
A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic
acids for treatment of nasolabial folds.
Dermatol Surg.
2007;
33
(Suppl 2)
S144-S151
MissingFormLabel
- 25
Moers-Carpi M M, Tufet J O.
Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction
of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled,
split-face trial.
Dermatol Surg.
2008;
34
210-215
MissingFormLabel
- 26
Carruthers J, Carruthers A.
A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox)
and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with
NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment
of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative
and BTX-A.
Dermatol Surg.
2003;
29
802-809
MissingFormLabel
- 27
Onesti M, Toscani M, Curinga G, Chiummariello S, Scuderi N.
Assessment of a new hyaluronic acid filler. Double-blind, randomized, comparative
study between Puragen and Captique in the treatment of nasolabial folds.
In Vivo.
2009;
23
479-486
MissingFormLabel
- 28
Kono T, Kinney B M, Groff W F, Chan H H, Ercocen A R, Nozaki M.
Randomized, evaluator-blind, split-face comparison study of single cross-linked versus
double cross-linked hyaluronic acid in the treatment of glabellar lines.
Dermatol Surg.
2008;
34
(Suppl 1)
S25-S30
MissingFormLabel
- 29
Glogau R G, Kane M A.
Effect of injection techniques on the rate of local adverse events in patients implanted
with nonanimal hyaluronic acid gel dermal fillers.
Dermatol Surg.
2008;
34
(Suppl 1)
S105-S109
MissingFormLabel
- 30
DeLorenzi C, Weinberg M, Solish N, Swift A.
The long-term efficacy and safety of a subcutaneously injected large-particle stabilized
hyaluronic acid-based gel of nonanimal origin in esthetic facial contouring.
Dermatol Surg.
2009;
35
(Suppl 1)
313-321
MissingFormLabel
- 31
Friedman P M, Mafong E A, Kauvar A N, Geronemus R G.
Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue
augmentation.
Dermatol Surg.
2002;
28
491-494
MissingFormLabel
- 32
Grimes P E, Thomas J A, Murphy D K.
Safety and effectiveness of hyaluronic acid fillers in skin of color.
J Cosmet Dermatol.
2009;
8
162-168
MissingFormLabel
Jonathan M. SykesM.D.
Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology–Head
and Neck Surgery
2521 Stockton Blvd, Suite 6206, Sacramento, CA 95817
eMail: jonathan.sykes@ucdmc.ucdavis.edu